Compagnie Lombard Odier SCmA’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.09K Hold
1,055
﹤0.01% 431
2026
Q1
$5.22K Hold
1,055
﹤0.01% 400
2025
Q4
$4.93K Hold
1,055
﹤0.01% 397
2025
Q3
$5.02K Hold
1,055
﹤0.01% 416
2025
Q2
$3.27K Hold
1,055
﹤0.01% 407
2025
Q1
$3.5K Sell
1,055
-7,000
-87% -$24.6K ﹤0.01% 446
2024
Q4
$25.1K Hold
8,055
﹤0.01% 378
2024
Q3
$29.3K Sell
8,055
-8,000
-50% -$32.5K ﹤0.01% 373
2024
Q2
$73.5K Hold
16,055
﹤0.01% 308
2024
Q1
$79.2K Hold
16,055
﹤0.01% 325
2023
Q4
$75.6K Hold
16,055
﹤0.01% 373
2023
Q3
$40.9K Hold
16,055
﹤0.01% 439
2023
Q2
$71.9K Hold
16,055
﹤0.01% 384
2023
Q1
$79.8K Hold
16,055
﹤0.01% 395
2022
Q4
$33K Buy
16,055
+10,000
+165% +$22.5K ﹤0.01% 529
2022
Q3
$16K Buy
+6,055
New +$21.2K ﹤0.01% 545
2022
Q1
Sell
-7,975
Closed -$113K 675
2021
Q4
$113K Hold
7,975
﹤0.01% 423
2021
Q3
$140K Buy
+7,975
New +$140K ﹤0.01% 396

Other funds holding SOPH

Compagnie Lombard Odier SCmA's SOPH Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 1,055 shares worth $6.09K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

Compagnie Lombard Odier SCmA first reported a position in SOPH in Q3 2021 and has held it in 18 quarters since. The position peaked at $140K in Q3 2021. 19 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 1,055 shares of SOPHiA GENETICS worth $6.09K as of Q2 2026.
  • Compagnie Lombard Odier SCmA left its SOPHiA GENETICS share count unchanged in Q2 2026.
  • SOPHiA GENETICS made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #431 holding.
  • Compagnie Lombard Odier SCmA first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 18 quarters since.
  • Compagnie Lombard Odier SCmA's SOPHiA GENETICS position peaked at $140K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.